Navigation Links
First Animated Instructional Oral Sex Video Reaches Mainstream America, Despite the Touchy and Controversial Subject Matter
Date:2/5/2010

On February 4, 2010, Charlemagne Educational Marketing, LLC launched the release of Swiggs™, the very first live action and animated educational DVD teaching the fine art of oral sex, without nudity.

Atlanta, GA (PRWEB) February 5, 2010 -- On February 4, 2010, Charlemagne Educational Marketing, LLC launched the release of Swiggs™ at www.swiggsandswizzles.com the very first live action/animated instructional video teaching both women and men the fine art of oral sex. Since many have produced dry, boring, and cricket-chirpingly- awkward styled sex education videos, Charlemagne decided to take a different approach. Addressing the need for a direct, informative, easy-to-watch instructional video on how to perform a "blow job," Swiggs supplies step-by-step techniques and ideas that are easy to understand, detailed, and effective. This is not a clinical video, nor is it pornographic. Swiggs uses real actors accompanied by animation for the necessary instructional aspects of the anatomy. Intended for a broad audience ranging from novices to the experienced, Swiggs mixes humor with abundant information to teach the various effective methods for success and to dispel some incorrect notions about what does or does not work. Making a taboo subject matter mainstream so that women don't have to fumble their way through the back pages of an adult magazine or on nefarious sites online, Swiggs delivers the information to mainstream America.

Charlemagne Educational Marketing, LLC was founded in 2009 in Atlanta, GA with the purpose of delivering high quality instructional sex education videos that would provide information without the use of nudity, yet keeping the viewer e
'/>"/>

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Page: 1 2

Related medicine news :

1. Hillenbrand Reports Results for First Quarter 2010
2. MedCath Corporation Reports First Quarter Earnings
3. New Orleans Saints Offensive Line Honored with First Madden Most Valuable Protectors Award Presented by Prilosec OTC(R)
4. Medical Mutual is the First Ohio Health Plan to Receive NCQA Wellness & Health Accreditation
5. Angel.com Launches Caller First IVR Solutions with AstraZeneca
6. Human Touch Unveils HT-Connect™, the First Personalized Wellness Solution Wirelessly Connecting Human Touch Massage Chairs with iPhone and iPod Touch
7. Sunquest Introduces First Business Intelligence Solution in Laboratory Marketplace
8. World Vision: Vulnerable Must Be First in Line at Launch of City-Wide Food Distributions in Haiti
9. Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal Year 2010
10. Abba House Partners With Global Vision Technologies - First Adult Residential Case Management System of Its Kind
11. CPI International to Announce First Quarter 2010 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
First Animated Instructional Oral Sex Video Reaches Mainstream America, Despite the Touchy and Controversial Subject Matter
(Date:4/22/2014)... DC (April 22, 2014) The International Communication ... 22-26 in Seattle, Washington. The theme of the ... means in a networked and digital society. , ... attended by over 2,200 Communication scholars representing over ... scholarly international communication conference in the world. This ...
(Date:4/22/2014)... German . , ... their mode of action is complex: In low concentrations ... while at high concentrations they can cause "oxidative stress", ... redox signaling unfolds in single cells and organelles in ... jointly by the teams of LMU Professor Martin Kerschensteiner ...
(Date:4/22/2014)... CITY)A computational tool developed at the University of Utah ... gene mutations in three separate cases, U of U ... in The American Journal of Human Genetics . ... identifies undiagnosed illnesses and unknown gene mutations by analyzing ... code for genes are made, in individual patients and ...
(Date:4/22/2014)... researchers have demonstrated the first size-based form of ... membranes of living cells. This unique physical approach ... critical to whether a cell lives or dies, ... obtained through conventional microscopy. , "We,ve developed membrane-embedded ... to both probe and manipulate membrane assemblies, including ...
(Date:4/22/2014)... parallel with modern man ( Homo sapiens ), there were ... side by side, such as Neanderthals and the recently discovered ... survived. What was it in our genetic makeup that gave ... known about our unique genetic makeup as distinguished from our ... we are the only species among them ,to survive. Even ...
Breaking Medicine News(10 mins):Health News:International Communication Association to hold Annual Conference in Seattle, Washington 2Health News:Neuroimaging: Live from inside the cell 2Health News:Applying math to biology: Software identifies disease-causing mutations in undiagnosed illnesses 2Health News:Applying math to biology: Software identifies disease-causing mutations in undiagnosed illnesses 3Health News:First size-based chromatography technique for the study of livi 2Health News:First size-based chromatography technique for the study of livi 3Health News:What gave us the advantage over extinct types of humans? 2
... 11, 2008 The American Cancer Society announced today ... for Exemplary Leadership in Tobacco Control. The awards are ... L. Terry, M.D., who led the landmark 1964 Surgeon ... and other illnesses. Dr. Terry,s courageous and groundbreaking work ...
... Deanna Vankessel, author of the recently published G lobal Markets ... to offer extensive expertise on the recent FDA premarket approval recommendation of ... , , MRG,s Deanna Vankessel is available ... , How ...
... Begin in December - , , ... Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE ), ... neratinib (HKI-272) in women with advanced HER-2-positive breast cancer. These ... breast cancer positive for the ErbB-2 receptor (also known as HER-2 ...
... Health Company (NYSE Alternext: FHC) has announced that the U.S. ... Committee has unanimously voted that the company,s second-generation female condom, ... , , The Advisory ... condition that the FC2 Female Condom,s instructions for use continue ...
... with ribavirin for previously untreated children with chronic hepatitis ... , KENILWORTH, N.J., Dec. 12 Schering-Plough ... the U.S. Food and Drug Administration (FDA) has granted ... USP) combination therapy for use in previously untreated patients ...
... Case Medical Center in conjunction with Sodexo Health Care Services ... 24/6 unit, the original certified kosher hot food vending machine. ... in the state of Ohio, offering patients and their caregivers ... , University Hospitals prides itself ...
Cached Medicine News:Health News:American Cancer Society recognizes international tobacco control leaders 2Health News:American Cancer Society recognizes international tobacco control leaders 3Health News:American Cancer Society recognizes international tobacco control leaders 4Health News:American Cancer Society recognizes international tobacco control leaders 5Health News:American Cancer Society recognizes international tobacco control leaders 6Health News:Millennium Research Group Analyst Available to Comment on FDA's Premarket Approval Recommendation of Genzyme Biosurgery's Synvisc Single-Injection Product for the Knee 2Health News:Wyeth Announces Positive Data from Phase 2 Study of Neratinib in Advanced HER-2-Positive Breast Cancer 2Health News:Wyeth Announces Positive Data from Phase 2 Study of Neratinib in Advanced HER-2-Positive Breast Cancer 3Health News:Wyeth Announces Positive Data from Phase 2 Study of Neratinib in Advanced HER-2-Positive Breast Cancer 4Health News:FDA Advisory Committee Votes Unanimously that FC2 Female Condom(R) is Approvable 2Health News:FDA Advisory Committee Votes Unanimously that FC2 Female Condom(R) is Approvable 3Health News:FDA Advisory Committee Votes Unanimously that FC2 Female Condom(R) is Approvable 4Health News:FDA Advisory Committee Votes Unanimously that FC2 Female Condom(R) is Approvable 5Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 2Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 3Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 4Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 5Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 6Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 7Health News:University Hospitals Case Medical Center Installs First Hot Kosher Vending Machine 2Health News:University Hospitals Case Medical Center Installs First Hot Kosher Vending Machine 3
(Date:1/15/2014)...  Echo Therapeutics, Inc. (Nasdaq: ECTE ) ("Echo"), ... as a non-invasive, wireless continuous glucose monitoring system, today ... and Interim CEO of Echo Therapeutics, will present at ... Mr. Doman will make a corporate ...
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com announces ... available in its catalogue: ... Worldwide Analysis http://www.reportlinker.com/p01957812/Insulin-Pump-Market--Forecast-–-Worldwide-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply ... Insulin Pumps are ...
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com announces ... available in its catalogue: ... Drug Delivery Systems -- Focus on End ... STUDY OBJECTIVES A drug ...
Breaking Medicine Technology:Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18
... ... ... ... ...
... ... ... ... ...
Cached Medicine Technology:InteractElsevier Delivers 3-D Interactive Anatomy Learning Tools 2InteractElsevier Delivers 3-D Interactive Anatomy Learning Tools 3InteractElsevier Delivers 3-D Interactive Anatomy Learning Tools 4InteractElsevier Delivers 3-D Interactive Anatomy Learning Tools 5InteractElsevier Delivers 3-D Interactive Anatomy Learning Tools 6InteractElsevier Delivers 3-D Interactive Anatomy Learning Tools 7InteractElsevier Delivers 3-D Interactive Anatomy Learning Tools 8InteractElsevier Delivers 3-D Interactive Anatomy Learning Tools 9InteractElsevier Delivers 3-D Interactive Anatomy Learning Tools 10Jiangbo Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2010 2Jiangbo Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2010 3Jiangbo Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2010 4Jiangbo Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2010 5Jiangbo Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2010 6Jiangbo Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2010 7Jiangbo Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2010 8Jiangbo Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2010 9Jiangbo Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2010 10Jiangbo Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2010 11Jiangbo Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2010 12Jiangbo Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2010 13Jiangbo Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2010 14Jiangbo Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2010 15Jiangbo Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2010 16Jiangbo Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2010 17Jiangbo Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2010 18Jiangbo Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2010 19Jiangbo Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2010 20Jiangbo Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2010 21Jiangbo Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2010 22Jiangbo Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2010 23Jiangbo Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2010 24Jiangbo Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2010 25Jiangbo Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2010 26
MDI will work with your facility to determine the best interim lab to fit your needs and your site....
... large number of mobile, modular and transportable ... fleet. The labs are typically leased to ... The Cath Lab Leasing Company allows hospitals ... upgrading existing equipment, initiating a new service ...
... PowerSuite holmium laser combines excellent cutting, ... virtually bloodless procedures. It is also ... gall bladder stones of all compositions, ... tool. Because its laser light is ...
... technology has allowed for perfecting mini-invasive endoscopic ... various pathologies with a considerable social impact. ... reducing the post-operatory times and represents a ... in all hospital structures.,DEKAs family of Nd:YAG ...
Medicine Products: